We show that CCN1/CYR61 signaling via α6β1, but not via αvβ3/αvβ5, drives an endocrine resistance phenotype that involves the unforeseen direct binding of CCN1 to ERα to regulate its transcriptional activity in breast cancer cells. The gene discussed is ESR1; the disease is breast cancer.